8
Participants
Start Date
November 30, 2015
Primary Completion Date
December 31, 2017
Study Completion Date
December 31, 2017
0.9% saline
0.25% bupivacaine hydrochloride injectable suspension USP
4mg/cc methylprednisolone acetate injectable suspension USP
Toronto Western Hospital, Toronto
University Health Network, Toronto
OTHER